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Capturing complex tumour biology 
in vitro: histological and molecular 
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Emmy W. Verschuren3,‡, Simon T. Barry1,‡, Heiko van der Kuip2,‡,  John A. Hickman7
Precision-cut slices of in vivo tumours permit interrogation in vitro of heterogeneous cells from solid 
tumours together with their native microenvironment. They offer a low throughput but high content 
in vitro experimental platform. Using mouse models as surrogates for three common human solid 
tumours, we describe a standardised workflow for systematic comparison of tumour slice cultivation 
methods and a tissue microarray-based method to archive them. Cultivated slices were compared 
to their in vivo source tissue using immunohistochemical and transcriptional biomarkers, particularly 
of cellular stress. Mechanical slicing induced minimal stress. Cultivation of tumour slices required 
organotypic support materials and atmospheric oxygen for maintenance of integrity and was 
associated with significant temporal and loco-regional changes in protein expression, for example 
HIF-1α. We recommend adherence to the robust workflow described, with recognition of temporal-
spatial changes in protein expression before interrogation of tumour slices by pharmacological or 
other means.
Cancers have been appropriately described as pathological organs1,2, where the complex interplay between 
a genotypically and phenotypically heterogeneous tumour and host cells in the stroma plays a key role in 
tumour development, progression and response to therapy3,4. Recapitulation of a complex and heteroge-
neous in vivo tissue or pathology by creating appropriate models in vitro is a challenging enterprise and 
studies of cancer cell biology and pharmacology demand that reductionist models attempt to capture, 
with optimal fidelity, key characteristics of a tumour and its supporting stroma. However, highly reduc-
tionist models, especially established cell lines growing in two dimensions on plastic5, neither capture 
three dimensional tumour architecture nor many of the important signalling dynamics of the interac-
tions between a tumour cell and its microenvironment. These signals play important roles in determining 
key aspects of tumour biology and pharmacology such as cell survival and sensitivity to drugs. Attempts 
to better represent the complexities of tumour biology, particularly the important architectural features 
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of growth, survival and motility in three dimensions, as well as to represent the gradients of nutrients 
and oxygen in a solid tumour, are being addressed through investigations of simple or complex tumour 
three dimensional spheroid models, mostly generated from established cell lines. These spheroid models 
sometimes have added elements of stroma, such as fibroblasts or endothelial cells6,7. Recently, by using 
carefully selected growth media, the generation of tissue and tumour organoids from normal or tumour 
stem cells in vitro has opened up new opportunities for the study of heterogeneous tissue and tumour 
architecture8. Nevertheless, the complexity observed in vivo is only partially reconstructed in vitro by 
laboratory manipulation of established cell lines or pluripotent stem cells and components of the stroma 
are often absent.
A potentially more complete in vitro representation of tumour architecture, heterogeneity and the 
complexity of a tumour in situ is provided by precision-cut slices (also known as organotypic cultures). 
Such 200–300 micron precision-cut slices capture both the three-dimensional architecture and full heter-
ogeneity of the tumour of interest, in addition to potentially retaining important native cellular elements 
such as immune, vascular and mesenchymal cells6. A growing number of publications are using tumour 
tissue slice culture as a method to address sensitivities to anti-tumour drugs, in the context of precision 
medicine9–13. However, there is no standardised approach to cultivating tumour slices, and little is known 
about the impact of slicing on tissue integrity and function. We wished to determine whether freshly 
prepared, precision cut slices are capable of capturing and then maintaining essential features of the 
heterogeneous architecture and biochemistry of an in vivo tumour. Although the study has drug target 
validation and drug discovery in view (www.predect.eu), it is relevant to tumour biology in general, 
where it is increasingly clear that biochemical circuitry is influenced by tumour architecture and the 
microenvironment. Towards the goal of characterising precision-cut slices, we first asked what were the 
biochemical consequences, measured by both selected transcript profiling and immunohistochemistry, 
of the transport after surgical removal of the in situ tumour, the subsequent manipulations necessary to 
provide precision-cut slices and then of the incubation of the slices themselves under various conditions 
in vitro with time. Such fundamental questions need to be answered before a slice can be interrogated as 
an appropriate surrogate for an in situ tumour; the potential trauma of removing, transporting and then 
slicing the tumour in addition to its subsequent incubation in vitro may “rewire” the biochemical cir-
cuitry of both the tumour and stromal cells. A major concern was the possible imposition of tissue stress 
responses on the biochemistry of slices and we asked, if so, whether this stress could be ameliorated.
We here address the technical issues regarding preparation and maintenance of precision-cut slices, 
using readily available tumour tissue from mouse models of human breast, prostate and lung cancers 
derived from both cell lines (CDX) and patient-derived human tumours (PDX) as xenografts, as well as 
a genetically engineered mouse model (GEMM) of non-small cell lung cancer. These models were nec-
essary surrogates for intensive technical studies that could not be readily performed with fresh human 
tumours, given their limited availability, intra-tumoural heterogeneity and reproducibility. We describe 
a workflow for slice preparation, cultivation and analysis that is amenable to bespoke optimisation. We 
propose this as a prerequisite baseline prior to planning any model-pertinent functional studies, such 
as drug perturbation. Additionally, to permit continuing interrogation of protein expression in slices by 
immunohistochemistry, we describe a novel method for preparing tumour slices as tissue microarrays 
(TMAs), permitting systematic archiving of large numbers of slice samples.
Results
Atmospheric oxygen levels and filter supports are required for retention of tissue morphol-
ogy in slices. We first compared previously published methods of slice cultivation to determine which 
conditions achieved maximal retention of tissue morphology and integrity. For this, tumour slices from 
breast, prostate and lung cancer in vivo models were cultivated for 48–96 h, either immersed in media 
(floating), or on a Millicell® filter support at an air-liquid interface (filter). Tumour slices were culti-
vated in either low oxygen conditions (L, < 5% O2) or in atmospheric oxygen (A, ~20% O2) (Fig.  1). 
Qualitative evaluation of H&E stained horizontal sections of tumour slices from all tumour types showed 
that cultivating slices on a filter support maintained a tissue morphology which was most similar to 
in vivo tissue morphology (Fig. 2a). In contrast, cultivation of floating tumour slices induced condensed 
apoptotic nuclei and vacuolated structures (Fig. 2a, arrows). Oxygen levels appeared to have little impact 
on the overall morphology of the lung H1437 CDX and 1647 PDX tumour slices. Interestingly, however, 
low oxygen impacted negatively on the morphology of MCF-7 CDX, PC295 PDX and lung GEMM 
tumour slices even when cultivated on filters (Fig. 2a). This was confirmed using a tissue segmentation 
algorithm, developed to quantify the level of viable and necrotic tissue present in H&E stained sections 
from lung GEMM tumour slices. 96% of the GEMM tissue was found to be viable when cultivated in 
atmospheric oxygen on a filter whereas viability was below 10% in all other conditions (Fig.  2b). The 
need for high oxygen levels as well as organotypic filter support for maintaining tissue integrity in MCF-7 
CDX tumours was confirmed by the finding that cell-cell contacts were lost when slices were cultivated 
at low oxygen tension and/or as floating cultures, as revealed by E-cadherin staining (Supplementary Fig. 
1a). Analogous results were found regarding hormone receptor expression in breast and prostate tumour 
slices. Expression of the oestrogen receptor (ER) and androgen receptor (AR) was sustained only in the 
presence of atmospheric oxygen together with filter supports (Fig. 2c, Supplementary Fig. 1b,e). Finally, 
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IHC staining for proliferation and apoptosis indicates that both atmospheric oxygen and organotypic 
filter supports are important to retain viability (Fig. 2c, Supplementary Fig. 1b–e).
Using histopathological methods we conclude that the viability of tissues, derived from different 
tumour models (CDX, PDX, GEMM) and pathologies (breast, lung, prostate), is best maintained when 
slices are cultivated on organotypic filter supports with atmospheric oxygen. Preliminary experiments 
with two primary human ER positive (ER+) breast tumours showed that the importance of using a filter 
support for primary tissue viability was variable. Slices from one tumour required a filter support for 
retention of ER+ cells. However, ER+ cells were retained in slices from a second tumour cultivated both 
with and without filter supports (Supplementary Fig. 1g).
The reproducibility of ER expression in tissue slices of four ER positive breast cancer MCF-7 CDX 
tumours cultivated on organotypic filter inserts with atmospheric oxygen is illustrated in Supplementary 
Fig. 1f. Expression of the ER was assessed immediately after slice preparation (0 h), or after 48 h of cul-
tivation (Supplementary Fig. 1f). ER levels observed immediately after slicing were maintained similarly 
to those observed in vivo. After cultivation of MCF-7 tumour slices for 48 h, ER levels in each individual 
slice remained similar, with little variability between slices. Similar results were obtained using slices 
from the PC295 prostate PDX (data not shown) supporting good inter-experimental reproducibility.
Cultivation of tumour slices induces changes in key stress pathways. To complement the his-
tological analysis of slices and to have a wider view of the impact of slice cultivation on tissue viability, 
we analysed changes in expression of genes thought to be biomarkers related to cellular stress in tumour 
slices using Fluidigm microfluidic dynamic qPCR arrays (48.48 and 96.96 chip formats), in combination 
with 134 TaqMan® assays. The choice of transcripts was either based on a known role of the respec-
tive proteins in cellular stress pathways (< 15% of the transcripts) or according to the following crite-
ria (> 85%): (i) they are typical targets of stress-activated transcription factors (such as p53 or NFkB), 
(ii) they are differentially regulated upon inhibitors/siRNA treatment specifically blocking certain stress 
pathways (such as the p38/JNK pathway) or (iii) the promoter regions of their genes have been described 
to contain stress response elements (such as endoplasmic reticulum (er) stress response elements). A 
full list of transcripts and their functional classification can be found in Supplementary Table 1. We 
hypothesised that the conditions for preparation of slices (the tumour transport and cutting) and their 
subsequent incubation were both likely to induce stress. Tumour slices were analysed at either 48 h or 
72 h (H1437 CDX and 1647 PDX), and an additional sample that had been sliced but not cultivated (day 
0) was analysed to assess the immediate impact of transportation and mechanical slicing on biomarker 
expression following tumour excision (Fig. 1).
To compare the overall impact of changes in stress related biomarkers for each cultivation condition, 
we used Principal Component Analysis (PCA) and Euclidian distance scores (Fig. 3). Importantly, only 
limited stress biomarker transcript expression changes were detected in the tissue slice prior to cultiva-
tion, i.e. directly after slicing (day 0; Fig. 3a–d, Fig. 4a). In accordance with the histological observations 
(Fig. 2), the data showed that filter-supported cultures in atmospheric oxygen clustered closest to in vivo 
Figure 1. Tumour tissue slice culture workflow. Fresh tumours were harvested from the mice and 
mounted on a tumour specimen platform, either directly or mounted in agarose. The Leica VT1200S 
vibrating microtome was used to cut slices of 200–300 μ m in thickness. Some sliced samples were fixed 
and frozen at day 0 prior to cultivation and the remainder were cultivated. Experiments were performed 
to compare the impact of filter supports and oxygen levels on tissue viability, which was estimated using 
either histological, immunohistochemical or RNA transcript-based biomarkers. Slices were sectioned both 
horizontally and vertically for analysis of morphology and of protein expression by immunohistochemistry.
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and day 0 samples except for MCF-7 (Fig. 3a–d). This was confirmed by Euclidean distance scores that 
represent the relationship between cultivated slice samples and the in vivo samples (Fig. 3e–h) and by the 
absolute number of significantly changed transcripts (Fig. 4a). The fold-change of individual biomarker 
transcripts is represented in Supplementary Table 2.
Although changes in biomarkers were generally consistent between the different models, we identified 
changes specific to individual models that would require consideration when using slices for functional 
studies. For example, in our hands, MCF-7 CDX tissue slices cultivated floating without filter supports 
were observed to undergo a substantial loss of tissue architecture and cell viability (Fig. 2a). As a conse-
quence, insufficient RNA of quality was able to be extracted for biomarker analysis. Unlike the lung and 
prostate models, MCF-7 CDX tissue slices, cultivated on filter supports either in atmospheric or low oxy-
gen, clustered together in the PCA plot and Euclidean distance scores showed no difference between the 
two conditions of oxygenation (Fig. 3a,e, Supplementary Fig. 2a,b). This is in contrast to the histological 
findings where tissue integrity and cell-cell contacts were lost in slices cultivated in low oxygen on filters 
(Fig. 2, Supplementary Fig. 1a,b). Detailed examination of MCF-7 CDX tissue slices cultivated on filters 
in low oxygen revealed that the majority of cells that experienced a lack of oxygen had poor viability 
(Supplementary Fig. 2c). This highlights the need for a suite of biomarker approaches, both histological 
and pathway-based, to drive baseline characterisation and refinement of slice cultivation protocols for 
individual tumour types.
Classification of stress-related transcripts according to their involvement in cellular processes 
(Supplementary Table 1) revealed that the majority of the transcripts down-regulated during slice culti-
vation, under conditions classed as suboptimal (low oxygen and/or without filter support), are involved 
Figure 2. Histopathology of cultivated tumour slices. (a) High power images of H&E stained tumour 
tissue slice sections, representing each tumour model cultivated under different conditions, compared to a 
stained section of the original in vivo tumour (CDX = cell line-derived xenograft; PDX  = patient-derived 
tumour; GEMM  = genetically engineered mouse model). Rows H1437 CDX and 1647 PDX: arrows indicate 
condensed nuclei (apoptosis) and vaculated regions. Representative images from at least three experiments 
are shown. Scale bars represent 25 μ m. (b) Heatmap of the percentage of viable tissue in NSCLC GEMM 
tumour slices determined by the algorithm described in the Methods. (c) Heatmaps representing the 
percentage of positive cells expressing viability markers by immunohistochemistry (IHC) of slices cultured 
under different conditions (numbers in heatmap boxes represent the percentage of positive cells for each 
biomarker). Key to conditions: A – atmospheric oxygen, L – low oxygen. Ki67, indicating proliferation; 
ClCK18, cleaved cytokeratin 18 indicating apoptosis; ERα , estrogen receptor-alpha; AR, androgen receptor; 
CC3, cleaved caspase 3. The values reflect means from three independent experiments.
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in DNA damage response (DDR) pathways. Importantly, this pattern of change was seen for all model 
systems under suboptimal conditions (Fig.  4b–d). Although important changes in post-transcriptional 
regulation of the DDR during incubation under suboptimal conditions could be investigated further, 
these suboptimal conditions are not recommended for detailed interrogation of slices. Up-regulation of 
transcripts was predominantly observed for apoptosis-, er stress- and p38/JNK-related genes, and again 
was observed across all the models. In the two lung models, cell cycle-related transcripts were found to be 
up-regulated (Fig. 4b,c, Supplementary Table 2), whereas in prostate PC295 PDX and breast MCF-7 CDX 
slices, cell cycle related transcripts were generally down-regulated. To determine if there were transcrip-
tional changes common to all models, Venn diagrams were generated, comparing transcriptional changes 
occurring under both optimal (air, filter support) or suboptimal conditions (Supplementary Fig. 3). 
Under optimal conditions, comparing the changes in gene expression observed in three different xeno-
grafted cancers, only one gene, ATF3, was up-regulated in common. ATF3 is implicated in the unfolded 
protein response (UPR) and the endoplasmic reticulum (er) stress response (Supplementary Fig. 3a). A 
number of statistically significantly altered gene transcripts related to apoptosis, UPR/er stress and DDR 
were observed according to the particular model and conditions of incubation (Supplementary Fig. 3b). 
Under suboptimal cultivation conditions (no filter support or low oxygen with filter support), the 
down-regulation of BRCA1 and BLM (DDR) and up-regulation of HERPUD1 (see also Supplementary 
Table 1) was common to slices from all three tumour xenograft models (Supplementary Fig. 3c). These 
three changes, observed in common, could be investigated further as potential biomarkers of suboptimal 
slice cultivation conditions when analysis of the number of different models is increased. Under subop-
timal conditions there were other changes which were particular to slices derived from each pathology 
(Supplementary Fig. 3d).
Figure 3. Evaluation, by Principal Component Analysis (PCA), of the changes in stress biomarkers 
observed under different conditions of slice culture. (a–d) PCA plots of the expression of each of the 
134 stress genes quantified under different conditions of slice culture. (e–h) Scatterplots of the Euclidean 
distance of stress gene biomarker expression profiles of tumour slices compared to the expression profiles of 
the corresponding in vivo tumours. Key: A- atmospheric oxygen; L-low oxygen; +  = cultivation with a filter 
support; − = cultivation without a filter support. Results are from three independent experiments.
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Figure 4. Pathway changes induced by tumour slice culture. (a) Table showing the numbers of 
differentially expressed genes (DEGs) in prostate and lung models cultivated under different conditions. 
(b–d) Tables showing the numbers of DEGs under each cultivation condition and their associated functions 
for both of the lung tumour models and the prostate tumour model. Key: A- atmospheric oxygen, L-low 
oxygen, + cultivated with a filter support, –cultivated without a filter support, red  = increases in expression; 
green = decreases in expression. Results are from 3 independent experiments.
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Cultivation at an air-liquid interface, with a filter support, induces loco-regional changes in 
biomarkers. A tissue slice is a complex structure of finite depth and in order to evaluate loco-regional 
changes across the slice, formalin-fixed tumour slices were embedded in paraffin wax and either sec-
tioned horizontally (Fig. 5a,b) or vertically (Fig. 5c–f). H&E and immunohistochemical staining revealed 
changes in histology and protein expression patterns, denoting differences in viable and necrotic areas, 
when comparing the filter interface to the air interface of the tissue (Fig. 5). Slices of the lung GEMM 
tumour were found to contain larger areas of necrosis at the filter interface of the slice, shown by H&E 
staining (Fig. 5a). In slices of the PDX prostate tumour, although necrotic areas were not observed, AR 
Figure 5. Loco-regional changes in IHC biomarkers in tumour slices cultivated under optimal conditions 
(filter support, atmospheric oxygen). (a) Lung GEMM tumour slices, horizontally embedded, were found to 
contain large areas of necrosis at the filter interface of the slice. Scale bars represent 1000 μ m. (b) AR staining 
revealed that AR positive cells were in abundance at the air interface in prostate PDX tumour slices and were 
greatly reduced at the filter interface. Scale bars represent 1250 μ m. (c) H&E stained sections of vertically 
embedded MCF-7 CDX tumour tissue slices. Images show differences in tissue morphology dependent 
on their proximity to the air interface of the slice. (i) Arrows: areas of necrosis; arrowheads, vacuolated 
regions (ii) Arrow: mitotic figure. (d) H&E stained section of vertically embedded H1437 CDX tumour slice, 
showing similar morphology to that observed in MCF-7 tumour slices. (e) Immunohistochemical staining 
of HIF1α in MCF-7 tumour slices showed an accumulation of nuclear protein at the filter interface of the 
slice, and immunohistochemical staining of ER, which showed a reduction in staining at the filter interface. 
Scale bars represent 100 μ m. (f) Immunohistochemical staining for γ H2AX indicated an abundance of foci 
at the filter interface. F4/80 immunohistochemical staining showed that there was a propensity for F4/80 
positive macrophages to be found closest to the air interface. Membranous E-cadherin was present at both 
the filter and air interfaces. Scale bars represent 100 μ m. (g) The variability of HIF1α expression observed in 
MCF-7 CDX tumours in vivo compared with that in MCF-7 slices after 48 h (n = 17 tumours, 23 slices, ***p 
value < 0.0001) (h) The spatial distribution of HIF1α and ER across the thickness of the slice was quantified 
using a segmentation algorithm (see Methods). Each slice image was divided into 50 layers, 0 representing 
the layer closest to the air interface and 50 closest to the filter interface. Error bars represent standard 
deviation, n = 7 cultivated slices from three tumours.
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positive cells were only in abundance at the air interface (Fig. 5b). In a vertically sectioned slice of the 
MCF-7 CDX, the slice surface adjacent to filter showed vacuolation and evidence of apoptosis (Fig. 5c(i), 
arrows) whereas a thin layer of cells at the air interface contained tightly packed cells with evidence of 
mitotic figures (Fig. 5c[ii], arrow). Taken together, within two to four days of culture on organotypic filter 
supports, all models showed a proliferation/viability gradient with loco-regional changes in morphology 
(eg. Fig. 5d) and biomarker expression.
The gradients of biomarker expression observed were particularly associated with the morphologi-
cal changes observed in the MCF-7 CDX tissue slices in close proximity to the filter support and were 
coincident with accumulation of nuclear hypoxia inducible factor α (HIF1α ) (Fig. 5e) and γ H2AX foci, 
a marker of double strand breaks in DNA, indicating that cells in this slice compartment were hypoxic 
and stressed (Fig. 5f). The hormone receptor ER drives proliferation of MCF-7 cells14 and the reduction 
of ER positive staining in the filter region of the slice (Fig. 5e), was associated with HIF1α expression. 
There was variable expression of HIF1α in the MCF-7 xenografts in vivo and this variability was captured 
in the slices where, on cultivation under optimal conditions, hypoxia increased significantly (Fig.  5g). 
The inverse relationship between HIF1α and ER expression has been described previously15. After 48 h 
of incubation, quantification of HIF1α and ER in a spatial manner across the slice thickness was carried 
out using bespoke software (see Methods), quantitatively confirming an accumulation of HIF1α at the 
filter region of the slice and a coincident depletion in ER levels (Fig. 5h). After 48 h of incubation, slices 
measured 357 + 55.2  μ m (n = 7) estimated by using this software. MCF-7 slices were also cut at thick-
nesses between 175 μ m and 250 μ m and the expression of HIF1α assessed (Supplementary Fig. 4). The 
expression of HIF1α was not discernably different according to slice thickness.
As an assessment of mouse host infiltrate, IHC was performed with an antibody specific to mouse 
macrophages (F4/80 positive cells). This revealed that host stroma was retained in MCF-7 tumour slices, 
with macrophages detectable largely at the oxygenated region of the slice close to the air interface after 
48 h (Fig.  5f). The distribution of macrophages may be driven by migration, as indicated by pathway 
analysis of gene expression data (data not shown), and/or their death in the developing hypoxic areas of 
the slice. In contrast, membranous E-cadherin was retained at both the filter and air interface, but was 
noticeably reduced in the centre of the slice (Fig. 5f).
The loco-regional changes in biomarkers that developed as slices from human xenograft tumours 
(CDX and PDX) and a GEMM were incubated with a filter support in atmospheric oxygen, were also 
observed when the work-flow was applied to samples of human patient tumours (Fig. 6). In tissue slices 
from primary NSCLC, similar differences in the expression of the HIF1α and γ H2AX proteins were 
observed when comparing air and filter interfaces (Fig. 6a). In primary human breast tumours HIF1α 
was observed in 3 out of 4 tumours cultivated as slices with varying degrees of accumulation at the filter 
interface (Fig. 6b).
The type of slice support system impacts upon stress biomarker expression. Having estab-
lished that filter-supported cultivation was optimal, although associated with loco-regional changes in 
biomarker expression, we next investigated whether alternative support materials and incubation meth-
odology influenced the loco-regional changes. Changes in the type of the slice support material and 
methods of incubation indeed influenced the slice architecture and stress biomarker profile. Two types of 
Alvetex adherent filter supports and a tissue slice incubation unit that permits intermittent immersion of 
the slice into the media, were tested (Fig. 7). Intermittent immersion is a technique that has the potential 
to prevent establishment of a filter-air interface gradient, permitting oxygen access to both surfaces of 
the slice (see Methods). Consistent with the observation using Millipore filters, tumour slices cultivated 
statically using both types of Alvetex support accumulated HIF1α at the media interface (Fig. 7a). Using 
the tissue slice incubation unit, MCF-7 tissue slices were found to show expression of HIF1α only in 
the centre of the slice with both air sides staining negatively, indicative of an oxygen gradient from the 
two surfaces of the slice to the centre (Fig.  7a). When slices were cultivated using the incubation unit 
or with Alvetex or Millipore supports, PCA plots and Euclidean distance scores of stress biomarker 
transcript expression showed there were no differences between Millipore supports and the incubation 
unit for both breast CDX and prostate PDX slices (Fig. 7c,d,f). For breast CDX slices fewer changes in 
stress biomarker transcript expression were observed with the Alvetex supports (Fig. 7d). Importantly, 
cultivation of tissue slices from GEMM lung tumours using the incubation unit noticeably reduced the 
onset of necrosis observed at the filter side of Millipore supports (Fig. 7b). These data support the use 
of a range of cultivation platforms that can be assessed for each novel model to be investigated, offering 
the potential for modification of the oxygen and media gradients as appropriate.
Archiving of tumour slices. To permit further interrogation of tumour tissue slices by IHC and other 
FFPE methods, we tailored a method to punch tissue slice FFPE blocks and produce a tissue microarray 
(TMA). Using standard TMA punching to generate a tissue slice TMA from horizontally embedded 
tumour slices was challenging, as only small amounts of tissue material were present at the sectioning 
face, as shown in Fig. 8a. Vertically embedded tissue slices (see materials and methods) permitted robust 
and reproducible tissue slice punches (Fig. 8b).
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Figure 6. Observations made in murine CDX and PDX tumours were confirmed in patient tumour 
samples. (a) A NSCLC tumour from a patient was obtained, sliced and cultivated on filters for 72 h 
following the standard workflow. After this time, induction of HIF1α was observed at the filter interface 
of the slice. This was coincident with increased cleaved caspase 3 (CC3) and γ H2AX staining. Conversely, 
Ki67 positive cells were found at the air interface. (b) The induction of HIF1α at the filter interface was also 
observed in breast tumour slices prepared from samples of patient tumours. Slices from tumours 1 and 2 
show a clear accumulation of HIF1α at the filter interface, while slices from tumour 3 did not develop an 
accumulation of HIF1α after 72 h. Scale bars represent 100 μ m.
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Discussion
Tissue slice culture has the potential to permit the interrogation of complex, heterogeneous material 
from either human tumours or appropriate models whilst the tumour microenvironment is maintained. 
There are diverse publications suggesting that tumour tissue slice culture can be utilised productively 
using different cultivation protocols (reviewed in6). Studies so far have predominantly been performed 
using patient tumour samples. These reports are limited by their minimal biochemical characterisation 
of the impact of either slice preparation or cultivation conditions. Furthermore, a systematic comparison 
between different cultivation methods is lacking. This is mainly due to the difficulty in defining adequate 
controls using heterogeneous patient tumour tissues and the impossibility of showing reproducibility of 
results from ex vivo slices obtained from one unique human tumour. Across four independent laborato-
ries, we have developed a unified workflow using surrogate tumours from GEMM and xenograft models, 
a workflow which can also be applied to primary human tumours and may be adapted to other cancer 
pathologies. The consistent availability of this surrogate source of accessible and homogenous tumour 
material allowed us to systematically compare the in vivo tumour with tissue slices immediately after 
preparation and upon cultivation under various conditions. The use of such models to prepare slices 
is anyway pertinent to fulfilling the needs of investigators when multiple, repeated studies of tumour 
biochemistry or pharmacology are to be performed or when intensive efforts in industry are required, 
such as for target validation. We established a biomarker platform to determine how preparation and/
or cultivation might influence the activity of stress related pathways in tumour slices. In our hands, a 
single palpable murine tumour (minimum of 400mm3) was able to provide around 20 slices, permitting 
multiple investigations ex vivo of a single complex in vivo tumour, with the potential to reduce the use of 
animals in some studies. Importantly, both vertically and horizontally embedded slices were interrogated 
by microscopy and immunohistochemistry, permitting an analysis of the status of the interior of the slice 
and not only of its surface, as reported in other studies.
Importantly, we found for all three tumour types that tumour transportation and slicing had little 
impact on stress gene expression, but that the act of cultivation itself induced significant changes in gene 
and protein expression. The comparison of differently cultivated tissue slices revealed that the key param-
eters governing tissue viability are organotypic filter supports and oxygen levels. When cultivated as 
Figure 7. Comparison of slice support materials and slice incubation cultivation systems. (a) H&E 
stained and HIF1α immuno stained sections of MCF-7 CDX tumour slices cultivated using an adherent 
filter support with a 5 μ m pore size (Alvetex Strata), a 0.4 μ m pore size (Alvetex Polaris) and using a tissue 
slice incubation unit supported by titanium grids, which were periodically rotated into the media and air 
(see Methods). (b) H&E stained sections of Lung GEMM tumour slices annotated for regions of necrosis in 
slices cultivated using Millipore filters and a tissue slice incubation unit. Pink shaded areas indicate necrosis. 
(c–f) PCA plot of the stress gene biomarker expression profiles and corresponding euclidean distance 
scatterplots of MCF-7 CDX and PC-295 PDX tumour slices cultivated using different support methods. 
Scale bars represent 100 μ m. Key: M  = Millipore Filter, P = Alvetex Polaris Filter, S = Alvetex Strata Filter, 
IU = Tissue slice incubation unit. Results are from three independent experiments.
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floating slices in low oxygen there was a rapid and significant alteration of a number of stress pathways, 
accompanied by a loss of tissue integrity. This was ameliorated when slices were cultivated on organo-
typic filter inserts and, somewhat surprisingly, in atmospheric oxygen. Hypoxia is a hallmark of most 
solid tumours with oxygen levels of < 2% (mild hypoxia) and < 0.1% (severe hypoxia)16. Tissue normoxia 
is also far away from atmospheric oxygen with ~5% in the brain and ~6% in the lung17. Due to the loss 
of the intact circulatory network in a slice, the availability of oxygen in tissue slices is strictly limited to 
gas diffusion. This produces an oxygen gradient throughout the tissue slice analogous to that observed 
around vessels in vivo18. We presume that atmospheric concentrations of oxygen produce hyperoxic con-
ditions at the air side but allow a supply of just sufficient oxygen to deeper cell layers, distant from the air 
side. This is supported by our observation that in 3–5% oxygen only a very thin layer of cells at the air 
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Figure 8. Tissue Micro Array (TMA) workflow for the archiving of tissue slice material. (a) Schematic 
diagram of the generation of TMAs from horizontally embedded tumour slices, and the resultant incomplete 
tissue sections from these blocks. (b) Schematic diagram of the generation of TMAs from vertically 
embedded tumour slices, and the improvement in achieving consistent and complete tissue sections from 
these blocks.
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side survived. Importantly, histological analysis of organotypic filter-supported tissue slices, from either 
the murine models or human cancer tissue showed that a local microenvironment was established, orien-
tated between the air and filter interfaces. The development of loco-regional heterogeneity indicates that 
prudence is required when interpreting the data from studies such as pharmacological perturbation of a 
slice or explants9. However, gradients of oxygen tension are a common feature of solid tumours16 so that 
these conditions offer the potential to recapitulate an important aspect of in vivo tumour biology in vitro.
The kinetics of the onset of hypoxia in incubated slices was variable amongst the models and pathol-
ogies studied here, with slices from the MCF-7 CDX showing expression of HIF1α after only 24 h. The 
diffusion of oxygen and its utilisation will be controlled by several variables in a slice lacking a functional 
vasculature. Perhaps surprisingly, slice thickness was not a major determinant (Supplementary Fig. 4). 
Other potential factors include matrix stiffness, cellularity and the metabolic state of both carcinoma and 
stromal cells, including their proliferative status. It would be necessary to compare the stromal status 
(density of fibroblasts, vascular cells) and cellularity of a large series of tumours, preferably of the same 
pathology, together with their metabolic status before conclusions about determinants of the onset of 
hypoxia could be firmly determined. One of us (STB) determined that the stromal status of a variety 
of xenografted tumours was variable19. This provides the basis for a further in depth study of variables 
controlling the kinetics of the onset of hypoxia.
Our standardised workflow for tumour tissue slice preparation and culture, using filter support in 
atmospheric oxygen, enables implementation of a robust and routine platform. Importantly, when estab-
lishing tissue slice cultures it is essential to generate a baseline biomarker profile of the model of interest, 
analysing vertical sections of the slice, so that multiple samples from the same tissue of origin or from 
different pathologies can be compared. From this baseline it should be possible to develop the platform 
further, integrating developments in microfluidics and perfusion systems in order to optimise oxygen 
supply and further reduce cultivation-induced cell stress, thus permitting longer-term culture. The plat-
form permits future evaluation of the fidelity of signalling circuitry and the role of the native stroma in 
a heterogeneous cancer by immunohistochemical methods, using the archived TMAs. This offers a very 
powerful technique to investigate tumour biology and pharmacology in the context of a tissue, some-
thing that is missing from alternative in vitro models. Although advances have been made in generating 
cell lines from human cancers, for example from drug-resistant lung cancers20, unlike slices these often 
require specialised media, risking the selection of cells from a heterogeneous tumour. The use of slices 
also provides a means of interrogating tumours from PDX and advanced GEM models21,22 where it is 
sometimes difficult to derive cell lines for in vitro studies, and avoids the use of disaggregation systems. 
Tissue slice culture can be a valuable addition to the suite of ex vivo or in vitro assays that are used cur-
rently to study tumour biology, pharmacology and for the validation of tumour biomarkers on primary 
human tissue.
Methods
Tumour material from mice. All animal facilities and handling protocols were approved by the local 
committees on ethics of animal experiments, as required in each country, and adhered to the European 
Convention for Protection of Vertebrate Animals used for Experimental Purposes (Directive 2010/63/
EU). Experiments carried out with mice at AstraZeneca were compliant with the UK Animals (Scientific 
Procedures) Act, which is consistent with EU Directive 2010/63/EU and had undergone internal ethical 
review. Experiments with mice performed at Oncotest were scrutinised by the Committee on the Ethics 
of Animal Experiments of the regional council (Regierungspräsidium Freiburg, Abt. Landwirtschaft, 
Ländlicher Raum, Veterinär- und Lebensmittelwesen). In Helsinki, studies with mice followed guidelines 
from the Finnish National Board of Animal Experimentation, and were approved by the Experimental 
Animal Committee of the University of Helsinki and the State Provincial Office of Southern Finland 
(Licence number ESAVI-2010-04855/Ym-23). In Rotterdam, the protocols for the use of mice were 
approved by the Animal Experiments Committee, DECConsult, an independent committee responsible 
for accreditation of all animal experimentation under the Dutch Experiments on Animals Act and all 
protocols were reviewed so to adhere to the European Convention for Protection of Vertebrate Animals 
used for Experimental Purposes.
Cell line-derived xenograft (CDX) tumour samples. The CDX MCF-7 was derived by subcuta-
neous injection of 5 × 106 MCF-7 cells (American Type Culture Collection) per 0.1 ml in 50:50 basal 
media and Matrigel (BD Biosciences) into the left flank of male SCID mice (SCID/CB17). Animals were 
implanted with 0.5 mg/21 day 17β oestradiol pellets (Innovative Research of America) one day prior to 
cell implant.
The CDX NCI-H1437 was derived by subcutaneous injection of 5 × 106 NCI-H1437 cells (American 
Type Culture Collection) into the flank of 4–6 weeks old NMRI nu/nu mice.
Patient-derived xenograft (PDX) tumour samples. PDX from lung cancer (LXFA 1647) was 
derived from a metastasis in the adrenal gland of a 53 year old woman. 4–6 week old female NMRI nu/
nu mice under isoflurane anaesthesia receive tumour implants subcutaneously in the flank.
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PDX of prostate cancer (PC295) was established as described previously23. This PDX was routinely 
passaged by subcutaneous grafting of small fragments into both shoulders of intact male athymic 
NMRI nu/nu mice (Taconic) under isoflurane anaesthesia. Mice were supplemented with self-made 
testosterone-containing silastic implants as described previously24.
GEMM-derived primary NSCLC tumours. The conditional LSL-KrasG12D/+; Lkb1fl/fl (Kras;Lkb1) 
GEMM was used and maintained on a mixed genetic background. LSL-KrasG12D/+ 25 mice were pur-
chased from Jackson Laboratories and Lkb1fl/fl 26 were shared by Ron DePinho (Houston, TX, USA). Mice 
were anaesthetised with isoflurane, and tumour growth was initiated by intranasal delivery of Adenoviral 
CMV-Cre (3 × 107 pfu/mouse; Gene Transfer Vector Core) in 60 μ L volume, as previously described27.
Tumour harvesting. Xenografted tumours were harvested when the volume was between 0.4–1 cm3. 
Animals were euthanised by cervical dislocation and tumours were excised. A small sample of the tumour 
was either snap frozen or fixed in 10% neutral buffered formalin immediately after resection. Tumours 
were placed into ice-cold Oncostore Tumour storage solution (OncoScience AG) or ice cold Leibovitz 
L15 medium (Lonza) prior to tissue slicing. NSCLC GEMMs were euthanised by cervical dislocation 
when they showed laboured breathing. Lungs en bloc were harvested for tissue slicing or fixation with 
formalin.
Primary Patient Tumours. Breast tumour samples were obtained with fully informed consent 
from Wythenshawe hospital and transferred to AstraZeneca in ice-cold Oncostore tumour storage 
solution (OncoScience AG) on the day of surgical excision. The use of these samples was approved by 
AstraZeneca and The Manchester Cancer Research Centre Biobank (http://www.mcrc.manchester.ac.uk/
biobank/), which operates under HTA licence number 30004 and NRES ethics number 07/H1003/161+ 5 
in accordance with the approved guidelines. Fresh sterile tumour tissue of NSCLC patients was obtained 
as surgical waste from Klinik Schillerhöhe, Stuttgart immediately after surgical resection and maintained 
in organ transportation medium (Eurocollins, Germany) until use. The investigation was approved by the 
local ethics committee (159/2011BO2) and informed consent was obtained from the patients.
Tissue slice preparation and cultivation. Tumours were mounted onto the magnetic specimen 
holder of a Leica VT1200S vibrating blade microtome using cyanoacrylate adhesive. Tumours of small 
volume were first embedded in low temperature gelling agarose (Thermo) prior to mounting on the spec-
imen holder. Tumour tissue slices were prepared at a thickness of 200 μ m (mouse lung), 250 μ m (lung 
and breast) and 300 μ m (prostate) using the precision-cut vibrating-blade microtome (Leica VT1200S). 
Slices of < 175 μ m were found to be too fragile to manipulate. Slices were visually inspected whilst 
being cut to ensure the tissue was not compressed or torn, resulting in inconsistent slice thickness. It is 
of note that 3/21 primary human breast tumours received were unable to be sliced; the dense consist-
ency of these tumours prevented the blade from cutting the tumour. Lung PDX and CDX slices were 
cultivated in RPMI 1640, GEMM tumour slices were cultivated in F12 (Gibco), MCF-7 CDX slices 
were cultivated in DMEM (Sigma). Medium was supplemented with glutamine (2 mM; Gibco), peni-
cillin (100 U/ml; Gibco), streptomycin (100 μ g/ml; Gibco) and 10% foetal bovine serum (FBS; Gibco). 
Prostate PDX slices were cultivated in DMEM/F12 medium (Lonza, Belgium) supplemented with 2% 
FBS (Gibco), 1% insulin-transferrin-selenium (Gibco BRL), 0.01% bovine serum albumin (Boehringer 
Mannheim), 10 ng/ml epidermal growth factor (Sigma-Aldrich), penicillin/streptomycin antibiotics 
(100 U/ml penicillin, 100 μ g/ml streptomycin; Lonza) plus the following additions: 100 ng/ml fibronec-
tin (Harbor Bio-Products), 20 μ g/ml fetuine, 50 ng/ml cholera toxin, 0.1 mM phosphoethanolamine, 
0.6 ng/ml triiodothyronine, 500 ng/ml hydrocortisone and 0.1 nM synthetic androgen R1881 (all from 
Sigma-Aldrich)28. Primary breast tumour slices were cultivated in mammary epithelial cell medium sup-
plemented with bovine pituitary extract (0.004 ml/ml), Epidermal Growth Factor (recombinant human, 
10 ng/ml) insulin (recombinant human, 5 μ g/ml), hydrocortisone (0.5 μ g/ml, all from Promocell) and 
penicillin (100 U/ml; Gibco), streptomycin (100 μ g/ml; Gibco). Primary NSCLC tumour slices were cul-
tivated in RPMI 1640 supplemented with glutamine (2 mM; Gibco), penicillin (100 U/ml; Gibco), strep-
tomycin (100 μ g/ml; Gibco) and 10% fetal bovine serum (FBS; Gibco).
Cultivation was performed at 37°C and 5% CO2 in a humidified atmosphere under low oxygen 
(3–5% oxygen) or atmospheric oxygen (21% oxygen) conditions. Tissue slices were maintained sub-
merged in medium (floating), on Millicell Cell Culture inserts (Merck Millipore, PTFE, pore size 
0.4 μ m), on Alvetex Strata membranes (Reinnervate, polystyrene, pore size 5 μ m, http://reinnervate.
com/science-technical-resources/application-notes/maintenance-intact-tissues-using-alvetex-strata/), 
on Alvetex Polaris membranes (Reinnervate, pore size 0.4 μ m) or loaded onto titanium grids and rotated 
using a tissue slice incubation unit29,30 (Alabama Research & Development, http://www.alspi.com/incu-
bation.htm). An overview of cultivation conditions is shown in Table 1. Half of the medium was replen-
ished after 24 hours. Slices were harvested at various time points and either snap-frozen for RNA isolation 
or fixed in 10% neutral buffered formalin for immunohistochemistry (IHC). Fixed slices were embedded 
in paraffin either in vertical or horizontal orientation as indicated in Figs 1 and 5.
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TMA preparation from thin tissue slices. Tissue slices were collected as FFPE blocks from all 
tumour samples and archived centrally at The Institute for Molecular Medicine Finland (FIMM) as tissue 
microarrays (TMA). The TMA archive is used for comparison of protein expression profiles across the 
various PREDECT consortium platforms by centralised IHC. TMAs were constructed by punching two 
0.6 mm cores per sample from 30 vertically embedded tissue slices using a semi-automatic punching 
device (MiniCore). After arraying, we sectioned the TMA in 3.5 μ m sections on Superfrost objective 
glasses (Kindler O Gmbh) using Microm 355S microtome (Thermo Scientific). Sections were dried and 
stored at + 4°C. TMA sections were scanned at 0.22 micron resolution using Pannoramic P250 Flash 
whole slide scanner (3DHistech) equipped with 20× objective.
Immunohistochemical staining. For examination of histopathology, paraffin sections (3–4 μ m) were 
stained with hematoxylin and eosin. IHC staining was carried out by standard protocols. Briefly, sections 
were de-waxed in xylene and rehydrated in graded ethanol, heat mediated antigen retrieval of tissue 
sections was carried out before being allowed to cool. Specific antigen retrieval details for each tissue 
type are contained in Table 2. Endogenous peroxidases were blocked using 0.9–3% hydrogen peroxide for 
10 minutes (Fisher), and non-specific antibody binding blocked by incubation with serum free blocking 
solution (Dako) or 10% normal serum block for 30 minutes. Tissue sections were then incubated with 
primary antibodies, before being probed with secondary antibodies (Table 2). Antibodies were visualised 
using 3,3′ -diaminobenzidine (DAB) chromogen and counterstained with Meyer´s Hematoxylin (Dako) 
for 2 minutes. Sections were then dehydrated through graded alcohols, cleared in xylene and mounted.
Quantitation of IHC. IHC scoring was carried out manually or using computer supported IHC quan-
tification. Computer aided quantification was performed in whole tissue sections using the image analysis 
software Tissue Studio from Definiens or Aperio image analysis software (Aperio ePathology Solutions, 
Leica Biosystems). These programs allow quantification of the number of positively stained cells and the 
level of relative staining intensity in user defined regions of interest (ROI). Within these ROIs, algorithms 
were used that detect nuclei, membranous and cytoplasmic staining. Images were manually checked to 
ensure exclusion of mistakenly identified objects. Mean percentages of positively stained tumour cells 
from computer aided and manual IHC quantification were calculated across tumour types from at least 
three independent experiments. Statistical analysis was carried out using the student’s t test in GraphPad 
Prism (GraphPad Software). Spatial analysis of IHC images was carried out using bespoke in-house 
image processing algorithm for spatial feature detection in Matlab 13b (MathWorks). Slice images were 
compartmentalised arbitrarily into 50 layers, with each layer having an average thickness of 7.1 μ m ± a 
standard deviation of 1.1 μ m. ER H score was generated from ER staining quantified by image analysis 
software; it allows generation of a single figure that incorporates both the frequency of positively stained 
cells and the intensity of the staining. H scores were generated using the following formula: (1*per cent 
positive cells with intensity score 1) + (2*percent positive cells with intensity score 2) + (3*per cent 
positive cells with intensity score 3).
Support System Oxygen Level Models Tested
Floating/Unsupported Low
CDX: MCF-7, NCI-H1437
PDX: lung cancer LXFA 1647 (Oncotest), prostate 
cancer PC295
GEMM: Kras;Lkb1
Floating/Unsupported atmospheric
Millicell filter support, 0.4 μ m 
pore, non adherent (Millipore, 
#PICM 0RG 50/#PICM01250)
low
Millicell filter support, 0.4 μ m 
pore, non-adherent (Millipore, 
#PICM 0RG 50/#PICM01250)
atmospheric
Strata filter support, 5 μ m pore, 
adherent (Reinnervate) atmospheric
CDX: MCF-7
Polaris filter support, 0.5 μ m 
pore, adherent (Reinnervate) atmospheric
Tissue slice incubation unit, 
titanium grids (Alabama 
Research and Development)
atmospheric
CDX: MCF-7
PDX: prostate cancer PC295
GEMM: Kras;Lkb1
Floating/Unsupported atmospheric Primary patient: ER+ breast tumours
Millicell filter support, 0.4 μ m 
pore, non-adherent (Millipore, 
#PICM 0RG 50/#PICM01250)
atmospheric Primary patient: ER
+ breast tumours and NSCLC 
tumours
Table 1.  Summary of tested cultivation conditions and tumour models used.
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Tissue Type Primary Antibody Retrieval Secondary Antibody
MCF-7 CDX
Ki67 (MIB-1 clone, #M7240, 
Dako) 1:100, 60 mins, RT
pH6 antigen retrieval solution 
(Dako), 110 oC at pressure for 
2 mins
Envision+ anti-mouse secondary (Dako), 
30 mins, RT
Cleaved CK18 (M30 
Cytodeath, #12140322001, 
Roche) 1:200, 60 mins, RT
pH6 antigen retrieval solution 
(Dako), 110 oC at pressure for 
5 mins
Envision+ anti-mouse secondary (Dako), 
30 mins, RT
ERα (ID5 clone, #M704701, 
Dako) 1:200, 60 mins, RT
pH6 antigen retrieval solution 
(Dako), 110 oC at pressure for 
2 mins
Biotinylated anti-mouse secondary (Dako) 
30 mins, RT ABC amplification step 
(Vector Labs) 30 mins, RT
HIF1α (#610959, BD 
Biosciences) 1:50, 120 mins, RT
pH8 EDTA solution, 110 oC at 
pressure for 2 mins
Envision+ anti-mouse secondary (Dako), 
30 mins, RT
E-cadherin (24E10 clone, 
#3195, Cell Signaling 
Technology) 1:100, 60 mins, RT
pH6 antigen retrieval solution 
(Dako), 110 oC at pressure for 
2 mins
Biotinylated anti-rabbit secondary (Dako) 
30 mins, RT ABC amplification step 
(Vector Labs) 30 mins, RT
phospho-γ H2AX (#2577, Cell 
Signaling Technology)
pH9 retrieval solution (Dako), 
110 oC at pressure for 2 mins
Envision+ anti-rabbit secondary (Dako), 
30 mins, RT
F4/80 (Serotec, #MCA497G) 
1:200, 60 mins, RT
pH6 antigen retrieval solution 
(Dako), 110 oC at pressure for 
2 mins
Biotinylated anti-rat secondary (Dako) 
30 mins, RT ABC amplification step 
(Vector Labs) 30 mins, RT
Lung 
PDX and CDX 
Ki67 (MIB-1 clone, #M7240, 
Dako) 1:75, 30 mins, RT
pH6 antigen retrieval solution 
(Dako), steam heat for 30 mins
pH6 antigen retrieval solution (Dako), 
steam heat for 30 mins
Cleaved Caspase 3 (#9661, Cell 
Signaling) 1:75, 30 mins, RT
pH6 antigen retrieval solution 
(Dako), steam heat for 30 mins
Envision+ anti-mouse secondary (Dako), 
30 mins, RT
Prostate PDX
Ki67 (MIB-1 clone, #M7240 
Dako) 1:100, over night, 4°C
10 mM Na-citrate, pH6, at 99 oC 
for 20
DAKO EnVision Detection Kit, 
Peroxidase/DAB, Rabbit/Mouse; 30 mins. 
RT, DAB 2 × 5 mins
AR (#sp107, Cell Marque) 
1:200, over night, 4°C
10 mM Na-citrate, pH6, at 99 oC 
for 20
DAKO EnVision Detection Kit, 
Peroxidase/DAB, Rabbit/Mouse; 30 mins. 
RT, DAB 2 × 5 mins
Table 2.  Tissue specific conditions for immunohistochemical staining (RT - room temperature).
Quantitation of necrosis in GEMM slices. Necrotic regions in in vivo tumours, 0 h, and cultivated 
slices were manually drawn after pathologist’s review. A graphics-editing program (Adobe Photoshop 
CS6, Adobe Systems) was used to draw the masks (i.e. ROI and tumour necrosis) on top of a downscaled 
(0.88 μ m/pixel) versions of the original samples. During the process of drawing the masks, the full res-
olution whole-slide images were available in parallel to better discriminate the tissue morphology. The 
final tumour viability in the selected ROI was defined as a ratio of viable tumour tissue area in respect 
to the whole ROI area. The Matlab scientific computing environment was used to calculate the tumour 
viability measurements by importing the manually drawn image masks.
Total RNA extraction from tumour tissues. Total RNA was extracted from snap-frozen tissue 
slices. Tissue lysates were prepared using lysing matrix D with the FastPrep sample preparation system 
(MP Biomedicals). Subsequently, RNA extraction was carried out using the RNeasy Mini kit (Qiagen) 
and on-column DNase (Qiagen) digestion was performed to eliminate genomic DNA contamination.
cDNA synthesis and TaqMan-based qPCR. cDNA was generated using MMLV reverse transcriptase 
(Promega). Expression analysis was performed on the BioMark HD System (Fluidigm) according to 
manufacturer’s instructions. TaqMan assays were purchased from Applied Biosystems (Supplementary 
Table 1).
Gene expression analysis. Gene expression qPCR data was normalised to a housekeeping gene and 
converted to log2 values. Differentially expressed genes were found using limma package in R statistics 
environment31. Tumour number was included in the linear model to take heterogeneity between tumours 
into account. Genes with FDR corrected p-value less than 0.05 and log-fold change of at least one were 
considered as significant.
Euclidean distance (square root of the sum of square differences) was used to measure the difference 
of the slice models from the in vivo situation. Before calculating Euclidean distances and doing Principal 
Component Analysis (PCA)32, the function removeBatchEffect from limma R package was used to remove 
the effect of the tumour number. PCA was done using prcomp function in base R. Genes containing any 
missing values were removed before calculating principal components. First two components (having 
largest and second largest variance, respectively) were shown on the scatterplot.
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